Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pexelizumab: Updated Phase III data

Alexion Pharmaceuticals Inc. (ALXN), Cheshire, Conn.
Procter & Gamble Co. (PG), Cincinnati, Ohio
Product: Pexelizumab (5G1.1-SC)
Business: Cardiovascular
Molecular target:

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE